News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alfresa Holdings Corporation (ARHCF.PK) Files Manufacturing Approval For Modafinil For Narcolepsy


10/19/2005 5:13:08 PM

Tokyo (JCNN) - Alfresa Holdings (TSE: 2784) announced on April 15 that its wholly owned subsidiary Alfresa Pharma has filed an application for approval to manufacture modafinil for the treatment of narcolepsy, to the Ministry of Health, Labor and Welfare.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES